Loading…
Reported covered position: HELP Committee, Sen. Harkin, LA; Rep. Berry, L
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BAYER CORPORATION via EAST END GROUP, LLC
2022 · third_quarter · 3A
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislative and regulatory issues related to COVID-19 response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY via EAST END GROUP, LLC
2022 · third_quarter · 3A
Source: Senate LDA
| BAYER CORPORATION |
| 35 |
| 2015–2022 |
| PFENEX INC | 32 | 2011–2019 |
| ALERE INC. | 30 | 2011–2017 |
| SEQIRUS | 25 | 2016–2022 |
| SMITH & NEPHEW | 20 | 2013–2017 |
| ALVOGEN | 19 | 2018–2022 |
| MERCK & CO., INC. | 18 | 2010–2014 |
| BIOTECHNOLOGY INDUSTRY ORGANIZATION | 17 | 2010–2014 |
| MEDIMMUNE | 16 | 2010–2014 |
| ACHAOGEN INC | 13 | 2011–2013 |
| AMAZON | 12 | 2020–2022 |
| RAI SERVICES COMPANY | 12 | 2020–2022 |
| ALKERMES | 11 | 2014–2015 |
| Corbus Pharmaceuticals Holdings, Inc. | 11 | 2018–2020 |
| NANOINK, INC. | 11 | 2010–2012 |
| DAIICHI SANKYO INC | 10 | 2017–2019 |
| RIDGEBACK BIOTHERAPEUTICS | 10 | 2020–2022 |
| EMD SERONO, INC. | 9 | 2012–2013 |
| MESO SCALE DIAGNOSTICS | 9 | 2020–2022 |
| CUBIST PHARMACEUTICALS, INC. | 8 | 2010–2012 |
| EXELIXIS, INC. | 8 | 2018–2019 |
| GILEAD SCIENCES, INC. | 8 | 2012–2014 |
| ORGANOVO | 8 | 2016–2017 |
| FRESENIUS MEDICAL CARE NORTH AMERICA | 7 | 2021–2022 |
| PAXVAX | 7 | 2017–2018 |
| PHARMATHENE, INC. | 6 | 2010–2011 |
| VARIAN MEDICAL SYSTEMS, INC. | 6 | 2011–2012 |
| EISAI, INC. | 5 | 2010–2011 |
| EAST END GROUP, LLC | 3 | 2010 |
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; reforms to H.R. 3590, the Patient Protection and Affordable Care Act; regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: PAXVAX · Firm: EAST END GROUP, LLC
H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; Health and Human Services Appropriations, FDA regulatory issues and issues related to Priority Review Voucher programs.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Client: PAXVAX · Firm: EAST END GROUP, LLC
H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; Health and Human Services Appropriations, FDA regulatory issues and issues related to Priority Review Voucher programs.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
Prescription Drug User Fee Act Re-authorization; HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
Prescription Drug User Fee Act Re-authorization, H.R. 2025, the Abuse-Deterrent Opioids Plan for Tomorrow Act.
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Client: DAIICHI SANKYO, INC. · Firm: EAST END GROUP, LLC
HR 2025, Abuse-Deterrent Opioids Plan for Tomorrow Act; and FDA regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; issues related to the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; reforms to H.R. 3590, the Patient Protection and Affordable Care Act; regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
Issues relate to appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act related to diagnostics; issues related to diagnostics in the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; issues related to the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
Issues relate to appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act related to diagnostics; issues related to diagnostics in the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; issues related to the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Environmental Justice and Civil Rights Restoration and Enforcement Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; issues related to the 21st Century Cures Act; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
General health care coverage and reimbursement for prescription drugs; S. 2055, the Medical Countermeasure Innovation Act; regulatory issues related to biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Medical Countermeasure Innovation Act of 2016
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Medical Countermeasure Innovation Act of 2016
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to biodefense vaccine development and procurement; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
Medical Countermeasure Innovation Act of 2016
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues.
General health care coverage and reimbursement for prescription drugs; S. 2055, the Medical Countermeasure Innovation Act; regulatory issues related to biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Medical Countermeasure Innovation Act of 2016
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; implementation of and reforms to H.R. 3590, the Patient Protection and Affordable Care Act; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drug Administration legislative and regulatory issues, including the Prescription Drug User Fee Act Re-authorization.
Medical Countermeasure Innovation Act of 2016
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement for prescription drugs; S. 2055, the Medical Countermeasure Innovation Act and regulatory issues related to biodefense vaccine development and procurement; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Issues related to pandemic influenza funding, federal oversight of pandemic manufacturing facilities and passage of S 2055, the Medical Countermeasure Innovation Act.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drug Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ALERE INC. · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: GLAXOSMITHKLINE · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza and biodefense vaccine development and procurement; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to pandemic influenza vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: NOVARTIS · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; legislative and regulatory issues related to vaccine development; and the Food and Drug Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: AMGEN, INC, · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; and the Food and Drugs Administration legislative and regulatory issues.
Halt Tax Increases on the Middle Class and Seniors Act
Client: ASTRAZENECA · Firm: EAST END GROUP, LLC
General health care coverage and reimbursement; implementation issues regarding H.R. 3590, the Patient Protection and Affordable Care Act; the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: BAVARIAN NORDIC INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.
Pandemic and All-Hazards Preparedness Reauthorization Act of 2011
Client: PFENEX INC. · Firm: EAST END GROUP, LLC
Legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drug Administration legislative and regulatory issues.
Legislative and regulatory issues related to COVID-19 vaccine development.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via EAST END GROUP, LLC
2022 · third_quarter · 3A
General health care coverage and reimbursement for prescription drugs; drug pricing reform, including the 340b Program; and the Food and Drug Administration legislative, include the Prescription Drug User Fee Act Reauthorization and other regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via EAST END GROUP, LLC
2022 · third_quarter · Q3
Legislative and regulatory issues related to dialysis and kidney care services. Federal funding for preparedness efforts related to dialysis and kidney care services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY via EAST END GROUP, LLC
2022 · third_quarter · Q3
Legislative and regulatory issues related to COVID-19 vaccine development.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAZON via EAST END GROUP, LLC
2022 · third_quarter · Q3
Legislative and regulatory issues related to COVID-19 employer based testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2022 · third_quarter · Q3
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2022 · third_quarter · Q3
Legislatives issues related to pandemic preparedness and response. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2022 · third_quarter · Q3
Legislatives issues related to biodefense preparedness and response. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2022 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2022 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER CORPORATION via EAST END GROUP, LLC
2022 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislative and regulatory issues related to COVID-19 response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via EAST END GROUP, LLC
2022 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform, including the 340b Program; and the Food and Drug Administration legislative, include the Prescription Drug User Fee Act Reauthorization (PDUFA), Budget Reconciliation other regulatory issues.
General health care coverage and reimbursement for prescription drugs; drug pricing reform, included in Budget Reconciliation other regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via EAST END GROUP, LLC
2022 · second_quarter · 2A
General health care coverage and reimbursement for prescription drugs; drug pricing reform, including the 340b Program; and the Food and Drug Administration legislative, include the Prescription Drug User Fee Act Reauthorization and other regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via EAST END GROUP, LLC
2022 · second_quarter · Q2
Legislative and regulatory issues related to dialysis and kidney care services. Federal funding for preparedness efforts related to dialysis and kidney care services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIDGEBACK BIOTHERAPEUTICS via EAST END GROUP, LLC
2022 · second_quarter · Q2
Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY via EAST END GROUP, LLC
2022 · second_quarter · Q2
Legislative and regulatory issues related to COVID-19 vaccine development.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAZON via EAST END GROUP, LLC
2022 · second_quarter · Q2
Legislative and regulatory issues related to COVID-19 employer based testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2022 · second_quarter · Q2
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER CORPORATION via EAST END GROUP, LLC
2022 · second_quarter · Q2
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislative and regulatory issues related to COVID-19 response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via EAST END GROUP, LLC
2022 · second_quarter · Q2
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2022 · second_quarter · Q2
Legislatives issues related to pandemic preparedness and response. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2022 · second_quarter · Q2
Legislatives issues related to biodefense preparedness and response. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2022 · second_quarter · Q2
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2022 · second_quarter · Q2
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via EAST END GROUP, LLC
2022 · first_quarter · Q1
Legislative and regulatory issues related to dialysis and kidney care services. Federal funding for preparedness efforts related to dialysis and kidney care services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MESO SCALE DIAGNOSTICS via EAST END GROUP, LLC
2022 · first_quarter · Q1
Legislative and regulatory issues related to COVID-19 surveillance and diagnostic testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIDGEBACK BIOTHERAPEUTICS via EAST END GROUP, LLC
2022 · first_quarter · Q1
Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY via EAST END GROUP, LLC
2022 · first_quarter · Q1
Legislative and regulatory issues related to COVID-19 vaccine development.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAZON via EAST END GROUP, LLC
2022 · first_quarter · Q1
Legislative and regulatory issues related to COVID-19 employer based testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2022 · first_quarter · Q1
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2022 · first_quarter · Q1
Legislatives issues related to pandemic preparedness and response. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER CORPORATION via EAST END GROUP, LLC
2022 · first_quarter · Q1
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislative and regulatory issues related to COVID-19 response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via EAST END GROUP, LLC
2022 · first_quarter · Q1
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2022 · first_quarter · Q1
Legislatives issues related to biodefense preparedness and response. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2022 · first_quarter · Q1
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2022 · first_quarter · Q1
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
Legislative and regulatory issues related to COVID-19 vaccine development.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
Legislative and regulatory issues related to dialysis and kidney care services. Federal funding for preparedness efforts related to dialysis and kidney care services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MESO SCALE DIAGNOSTICS via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
Legislative and regulatory issues related to COVID-19 surveillance and diagnostic testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIDGEBACK BIOTHERAPEUTICS via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
Legislatives issues related to pandemic preparedness and response. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER CORPORATION via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislative and regulatory issues related to COVID-19 response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
Legislatives issues related to biodefense preparedness and response. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAZON via EAST END GROUP, LLC
2021 · fourth_quarter · Q4
Legislative and regulatory issues related to COVID-19 employer based testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via EAST END GROUP, LLC
2021 · third_quarter · Q3
Legislative and regulatory issues related to dialysis and kidney care services. Federal funding for preparedness efforts related to dialysis and kidney care services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MESO SCALE DIAGNOSTICS via EAST END GROUP, LLC
2021 · third_quarter · Q3
Legislative and regulatory issues related to COVID-19 surveillance and diagnostic testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIDGEBACK BIOTHERAPEUTICS via EAST END GROUP, LLC
2021 · third_quarter · Q3
Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY via EAST END GROUP, LLC
2021 · third_quarter · Q3
Legislative and regulatory issues related to COVID-19 vaccine development.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAZON via EAST END GROUP, LLC
2021 · third_quarter · Q3
Legislative and regulatory issues related to COVID-19 employer based testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2021 · third_quarter · Q3
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER CORPORATION via EAST END GROUP, LLC
2021 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislative and regulatory issues related to COVID-19 response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via EAST END GROUP, LLC
2021 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2021 · third_quarter · Q3
Legislatives issues related to pandemic preparedness and response. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2021 · third_quarter · Q3
Legislatives issues related to biodefense preparedness and response. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2021 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2021 · third_quarter · Q3
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via EAST END GROUP, LLC
2021 · second_quarter · Q2
Legislative and regulatory issues related to dialysis and kidney care services. Federal funding for preparedness efforts related to dialysis and kidney care services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via EAST END GROUP, LLC
2021 · second_quarter · RR
Legislative and regulatory issues related to dialysis and kidney care services. Federal funding for preparedness efforts related to dialysis and kidney care services.
AMAZON via EAST END GROUP, LLC
2021 · second_quarter · Q2
Legislative and regulatory issues related to COVID-19 employer based testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER CORPORATION via EAST END GROUP, LLC
2021 · second_quarter · Q2
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislative and regulatory issues related to COVID-19 response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via EAST END GROUP, LLC
2021 · second_quarter · Q2
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MESO SCALE DIAGNOSTICS via EAST END GROUP, LLC
2021 · second_quarter · Q2
Legislative and regulatory issues related to COVID-19 surveillance and diagnostic testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIDGEBACK BIOTHERAPEUTICS via EAST END GROUP, LLC
2021 · second_quarter · Q2
Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY via EAST END GROUP, LLC
2021 · second_quarter · Q2
Legislative and regulatory issues related to COVID-19 vaccine development.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2021 · second_quarter · Q2
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2021 · second_quarter · Q2
Legislatives issues related to pandemic preparedness and response. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2021 · second_quarter · Q2
Legislatives issues related to biodefense preparedness and response. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2021 · second_quarter · Q2
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2021 · second_quarter · Q2
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2021 · first_quarter · 1A
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MESO SCALE DIAGNOSTICS via EAST END GROUP, LLC
2021 · first_quarter · Q1
Legislative and regulatory issues related to COVID-19 surveillance and diagnostic testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIDGEBACK BIOTHERAPEUTICS via EAST END GROUP, LLC
2021 · first_quarter · Q1
Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY via EAST END GROUP, LLC
2021 · first_quarter · Q1
Legislative and regulatory issues related to COVID-19 vaccine development.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAZON via EAST END GROUP, LLC
2021 · first_quarter · Q1
Legislative and regulatory issues related to COVID-19 employer based testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2021 · first_quarter · Q1
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2021 · first_quarter · Q1
Legislatives issues related to pandemic preparedness and response. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER CORPORATION via EAST END GROUP, LLC
2021 · first_quarter · Q1
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislative and regulatory issues related to COVID-19 response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via EAST END GROUP, LLC
2021 · first_quarter · Q1
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2021 · first_quarter · Q1
Legislatives issues related to biodefense preparedness and response. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill and Supplemental Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2021 · first_quarter · Q1
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2021 · first_quarter · Q1
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN, INC, via EAST END GROUP, LLC
2020 · fourth_quarter · 4T
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMAZON via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
Legislative and regulatory issues related to COVID-19 employer based testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CORBUS PHARMACEUTICALS HOLDINGS, INC via EAST END GROUP, LLC
2020 · fourth_quarter · 4T
Drug Enforcement Agency scheduling of Cannabinoids. Legislative and regulatory issues related to Food and Drug Administration review of scheduled compounds.
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
MESO SCALE DIAGNOSTICS via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
Legislative and regulatory issues related to COVID-19 surveillance and diagnostic testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RIDGEBACK BIOTHERAPEUTICS via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
Legislative and regulatory issues related to pandemic and emerging infectious disease preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RAI SERVICES COMPANY via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
Legislative and regulatory issues related to COVID-19 vaccine development.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALVOGEN via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAYER CORPORATION via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislative and regulatory issues related to COVID-19 response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SEQIRUS via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
Legislatives issues related to pandemic preparedness and response. Funding for pandemic influenza in the LHHS Appropriations bill. Regulatory issues related to development and procurement of pandemic influenza vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVARTIS via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAVARIAN NORDIC INC. via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
Legislatives issues related to biodefense preparedness and response. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLAXOSMITHKLINE via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN, INC, via EAST END GROUP, LLC
2020 · fourth_quarter · Q4
General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE